Classifying as Debt vs. Equity to Raise Capital

By Wiss, Posted in Life Sciences

By Bill Beiermeister It can be tempting to use financial instruments to quickly raise cash, especially for technology and life sciences companies that must go through several rounds of financing before they can develop marketable product lines and begin generating income. But if you’re thinking about going this route, tread carefully. Some financial instruments must be treated as liabilities on your balance sheet if payment is demanded at certain times or under stated circumstances. Prospective comp... read more.